Enliven Therapeutics logo
Enliven Therapeutics
ELVN | NASDAQ
Chart Builder DCF Calculator
$47.62
-$1.18 (-2.42%)
At close: Nov 16, 2026, 4:00 PM ET
$47.62
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Enliven Therapeutics Cash Flow Statement

Cash flow statement explained
Fiscal Quarter
Period Ending
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
-27.7M -32.49M -23.63M -29.67M -20.15M -25.34M -28.54M -23.18M -23.16M -19.95M -22.74M -19.37M -20.77M -16.72M -14.72M -9.55M -10.55M -8.89M -8.67M -14.32M -13.65M -13.16M -10.26M
13K 7K 14K 46K 62K 81K 74K 80K 80K 78K 79K 78K 78K 74K 67K 64K 60K 52K 39K 33K 24K 25K 25K
8.06M 13.92M 7.4M 12.31M 7.19M 7.72M 6.8M 5.34M 5.18M 5.14M 4.52M 3.06M 3.4M 4.2M 2.26M 735K 1.1M 701K 654K – – – –
5.36M 897K -2.92M 391K 863K -476K -2.72M -833K 5.05M -2.78M -6.79M 6.43M 4.75M 1.42M -8.94M 588K -153K 420K -828K 895K 1.85M 2.2M -4.82M
-870K 637K 359K 253K -221K 160K 40K 1.07M 719K -1.32M -582K 2.46M -1.76M -831K – – 1.74M – – 1.02M 1.02M 948K 1M
– – – – – – – – – – – -4.17M – – – – – – – – – – –
7.95M -605K -3.43M 1.22M -157K 313K -2.5M -510K 4.99M -4.38M -4.64M 5.46M 3.15M 1.23M -8.45M 606K 1.21M 1.01M -2.39M 779K 1.7M 1.82M -3.79M
-12.56M -18.53M -19.29M -15.84M -13.28M -17.06M -24.13M -17.2M -12.19M -20.44M -23.36M -12.48M -15.89M -12.05M -20.84M -8.15M -6.45M -7.12M -10.36M -12.49M -10.9M -10.37M -13.02M
-94K -99K – – 1K -139K -20K – -22K -2K -20K -14K -16K -88K -31K -101K -14K -303K -194K – – – -12K
– – – – – – – – – – – – -40M – – – – – – – – – –
-45.97M -560.16M -65.84M -75.52M -71.86M -240.19M -59.23M -116.52M -234.23M -120.83M -56.78M -41.3M -75.53M -151.43M – – – – – -17.79M -22.23M -3.81M -3.72M
72.4M 118.69M 108.36M 87.69M 67.8M 56.74M 60.67M 117.24M 196.67M 77.17M 38.91M 80M 40M – – – – – – 3.3M 13.4M 7.2M 22.04M
– – – 213K – – – – 52.4M 10M – – 40M – – – – – – – – – –
26.33M -441.57M 42.53M 12.38M -4.06M -183.59M 1.43M 727K 14.83M -33.67M -17.89M 38.69M -35.55M -151.52M -31K -101K -14K -303K -194K -14.49M -8.83M 3.39M 18.3M
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
– 354K – – – – – 90.48M – – 270K – – -1.32M 74.4M -2.38M – – – – – – –
2.39M 463.42M 10.05M 623K -368K 218.38M 234K 39.97M 1.12M 1.81M 90.27M 90K -425K -2.82M 237.44M -2.38M 164K 5K 409K -10K 46.99M 1.66M 460K
16.16M 3.32M 33.29M -2.84M -17.71M 17.73M -22.47M 23.5M 3.75M -52.29M 49.02M 26.35M -51.87M -166.39M 203.9M -10.62M 19.06M -6.05M -11.83M -26.99M 27.26M -5.4M 5.74M
-12.65M -18.63M -19.29M -15.84M -13.28M -17.2M -24.15M -17.2M -12.22M -20.44M -23.38M -12.5M -15.91M -12.14M -20.88M -8.25M -6.46M -7.43M -10.56M -12.49M -10.9M -10.37M -13.03M
-20.71M -32.55M -26.69M -28.15M -20.46M -24.92M -30.95M -22.54M -17.39M -25.58M -27.9M -15.55M -19.31M -16.33M -23.14M -8.98M -7.56M -8.13M -11.21M -12.49M -10.9M -10.37M -13.03M
-13K -7K – – -1K -81K -20K – -22K -2K -20K -14K -16K -74K -31K -64K -14K -52K -39K – – – -12K
-81K -92K – – 2K -58K – – – – – – – -14K – -37K – -251K -155K – – – –
-12.57M -18.54M -19.29M -15.84M -13.28M -17.14M -24.15M -17.2M -12.22M -20.44M -23.38M -12.5M -15.91M -12.12M -20.88M -8.21M -6.46M -7.18M -10.4M -12.49M -10.9M -10.37M -13.03M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.